Danise Rogers Subramaniam

Title: Danise Rogers Subramaniam: Innovator in Antibody Research

Introduction

Danise Rogers Subramaniam is a prominent inventor based in Zionsville, Indiana. She has made significant contributions to the field of biotechnology, particularly in the development of humanized monoclonal antibodies. Her work focuses on addressing critical health issues, including obesity and certain cancers.

Latest Patents

Danise holds a patent for "Humanized anti-ghrelin antibodies." This patent includes humanized monoclonal antibodies and antigen-binding portions that effectively bind both acylated and unacylated human ghrelin. These antibodies are instrumental in neutralizing ghrelin activity, which is beneficial for treating disorders where ghrelin activity is harmful.

Career Highlights

Danise is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role involves extensive research and development in the field of antibody therapies. With her innovative approach, she has contributed to advancements that may lead to new treatments for obesity and related disorders.

Collaborations

Throughout her career, Danise has collaborated with notable colleagues, including David Matthew Marquis and Eric Michael Smith. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Danise Rogers Subramaniam is a trailblazer in the field of antibody research, with a focus on developing therapies that address significant health challenges. Her innovative work continues to pave the way for advancements in medical treatments.